|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.840 USD | +3.20% |
|
-.--% | - |
| 21/24/21 | Exscientia plc(NasdaqGS:EXAI) dropped from S&P Global BMI Index | CI |
| 20/24/20 | Recursion Pharmaceuticals, Exscientia Complete Business Combination | MT |
| Market Cap | 50Cr 67Cr 59Cr 54Cr 95Cr 6.4TCr 96Cr 646.62Cr 253.93Cr 3.15TCr 251.86Cr 246.38Cr 11TCr | P/E 2022 |
-4.55x | P/E 2023 | -4.28x |
|---|---|---|---|---|---|
| Enterprise Value | 16Cr 21Cr 18Cr 17Cr 30Cr 1.99TCr 30Cr 201.44Cr 79Cr 981.8Cr 78Cr 77Cr 3.38TCr | EV / Sales 2022 |
1.9x | EV / Sales 2023 | 14.2x |
| Free-Float |
36.87% | Yield 2022 * |
-
| Yield 2023 | - |
| 1 day | +3.20% |
| 3 years | 3.8 |  | 9.12 |
| 5 years | 3.8 | | 30.38 |
| 10 years | 3.8 | | 30.38 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Tech/Sci/R&D Officer | - | 01/05/2022 | |
| Chief Tech/Sci/R&D Officer | 61 | 06/06/2024 | |
John Overington
CTO | Chief Tech/Sci/R&D Officer | - | 01/05/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Mario Polywka
BRD | Director/Board Member | 63 | 28/09/2017 |
Elizabeth Crain
CHM | Chairman | 61 | 12/02/2024 |
Robert Ghenchev
BRD | Director/Board Member | 43 | 01/05/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.20% | -.--% | -.--% | -25.77% | 63Cr | |
| +0.58% | +2.06% | +3.90% | +10.40% | 5.07TCr | |
| -2.22% | -1.25% | +391.53% | +591.38% | 3.97TCr | |
| -0.54% | +0.39% | +27.67% | -3.89% | 3.47TCr | |
| -1.36% | +0.35% | +19.34% | +58.83% | 3.32TCr | |
| +1.21% | -4.58% | +3.00% | +37.03% | 2.68TCr | |
| -1.81% | -1.48% | - | - | 1.68TCr | |
| +0.51% | -3.47% | +66.38% | +125.61% | 1.54TCr | |
| +0.23% | -0.58% | +13.80% | +19.56% | 1.38TCr | |
| -0.62% | -3.09% | +11.43% | -29.93% | 1.28TCr | |
| Average | -0.08% | -0.75% | +59.67% | +87.02% | 2.45TCr | |
| Weighted average by Cap. | -0.47% | -0.23% | +82.52% | +125.72% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 2.72Cr 3.65Cr 3.2Cr 2.95Cr 5.17Cr 348.43Cr 5.25Cr 35Cr 14Cr 171.65Cr 14Cr 13Cr 590.09Cr | 2.01Cr 2.69Cr 2.36Cr 2.17Cr 3.81Cr 256.99Cr 3.87Cr 26Cr 10Cr 126.6Cr 10Cr 9.9Cr 435.24Cr |
| Net income | -12Cr -16Cr -14Cr -13Cr -23Cr -1.52TCr -23Cr -153.59Cr -60Cr -748.61Cr -60Cr -59Cr -2.57TCr | -15Cr -20Cr -17Cr -16Cr -28Cr -1.87TCr -28Cr -188.83Cr -74Cr -920.34Cr -74Cr -72Cr -3.16TCr |
| Net Debt | -49Cr -66Cr -58Cr -53Cr -93Cr -6.3TCr -95Cr -636.37Cr -249.91Cr -3.1TCr -247.87Cr -242.47Cr -11TCr | -34Cr -46Cr -40Cr -37Cr -65Cr -4.4TCr -66Cr -445.18Cr -174.82Cr -2.17TCr -173.4Cr -169.62Cr -7.46TCr |
Employees
483
- Stock Market
- Stocks
- EXAI Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
